ZIG The Acquirers ETF
S&P 500 TR USD

NAV as of 05-Dec-2022

27.1351

4 Week: 24.97 - 27.67

52 Week: 22.50 - 31.62

Latest Closing Price

26.95

Premium / Discount

-0.06

Expense Ratio

0.89%

Investment Objective

The investment seeks capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) and seeks to invests in equity securities of U.S.-listed companies that the fund’s investment adviser, believes to be undervalued, but fundamentally strong. The adviser typically selects approximately 30 stocks from the largest 25% of all stocks. The fund may invest in companies in any economic sector and may frequently and actively purchase and sell securities.

Main Fund Characteristics

Fund Manager:
Acquirers Funds
Asset Under Management:
40,702,723
Launch Date:
13/05/2019
Asset Class:
Equity
Replication Method:
Not Applicable
Number of Holdings:
34
Trading Currency:
USD
Style:
Mid Value
Region/Sector/Strategy:
N.A / N.A / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-14.661.53-9.59
1 Day-0.090.000.00
1 Week-2.351.91-1.23
1 Month6.537.630.86
3 Months6.6913.400.50
6 Months-3.3117.90-0.18
1 Year-12.9723.60-0.55
2 Years19.0126.650.71
3 Years0.3442.390.01
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.00000.0000-15.820937.4814
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.0000100.00002.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 34

Number of Bond Holdings: 0

Number of Equity Holdings: 30

Total Market Value: 40,702,723

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1United Therapeutics Corp4.36918,38301,893,217

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant5.87
Large23.49
Medium35.77
Small31.59
Micro2.96

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

13.5607

Price/Book*

2.0436

Price/Sales*

1.1114

Price/Cash Flow*

3.5421

Dividend Yield*

2.3994

Growth Measures

Long-Term Earnings

6.6382

Historical Earnings

27.2768

Sales Growth

14.0413

Cash-Flow Growth

28.3073

Book-Value Growth

18.0723

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.